AdityaBagrodiaMD

PubMed

• Complications and Surgeon Health: Resources for individuals and institutions.
  Gagan Prakash, Chloe E Peters, Gina Badalato, Lindsay A Hampson, Jay D Raman, Aditya Bagrodia> ;Urologic Oncology. 2024 Apr 8
• Metastasis-directed therapy in testicular cancer.
  Kshitij Pandit, Dhruv Puri, Nuphat Yodkhunnatham, Frederick Millard, Kit Yuen, Aditya Bagrodia> ;Current Opinion in Urology. 2024 Apr 3
• Characterization and impact of non-canonical WNT signaling on outcomes of urothelial carcinoma.
  Margaret Meagher, Harris Krause, Andrew Elliott, Alex Farrell, Elisabeth I Heath, Christina Jamieson, Tyler F Stewart, Matt Oberley, Rana R McKay, Emmanuel S Antonarak...> ;Cancer Medicine. 2024 Apr 1
• Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers.
  Crystal L Seales, Dhruv Puri, Nuphat Yodkhunnatham, Kshitij Pandit, Sarah Murray, Jane Smitham, John T Lafin, Kit Yuen, Aditya Bagrodia, Puri, D.> ;Cancers. 2024 Mar 31
• Impact of pathologic features on local recurrence in penile squamous cell carcinoma after penectomy.
  Eshan Joshi, Thomas Gerald, Samuel A Gold, Solomon L Woldu, Xiaosong Meng, Aditya Bagrodia, Kris Gaston, Vitaly Margulis> ;Surgical Oncology. 2024 Mar 19
• The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma.
  Priyanka Naik, Harshitha Dudipala, Yu-Wei Chen, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Therapeutic Advances in Urology. 2024 Feb 29
• The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study.
  Stewart, T. F., Margaret Meagher, Kylie M Morgan, Leah Deshler, Dhruv Puri, Kit Yuen, Aditya Bagrodia, Brent Rose, Tyler Stewart, Amirali Salmasi> ;Clinical Genitourinary Cancer. 2024 Feb 15
• Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness.
  Mehdi Kardoust Parizi, Vitaly Margulis, Aditya Bagrodia, Kensuke Bekku, Jakob Klemm, Akihiro Matsukawa, Arman Alimohammadi, Reza Sari Motlagh, Hadi Mostafaei, Ekaterin...> ;Urologic Oncology. 2024 Apr 1
• MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
  Yodkhunnatham, N., Pandit, K., Puri, D., Yuen, K., Bagrodia, A.> ;International Journal of Molecular Sciences. 2024 Feb 10
• Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy.
  Stephanie M Stanford, Tiffany P Nguyen, Joseph Chang, Zixuan Zhao, G Lavender Hackman, Eugenio Santelli, Colton M Sanders, Madhusudhanarao Katiki, Eleonora Dondossola,...> ;Science Advances. 2024 Feb 2
• Cost and utilization analysis of concurrent versus staged testicular prosthesis implantation for radical orchiectomy.
  Horns, J., Paudel, N., Nguyen, V., Walia, A., Bagrodia, A., Patel, D., Hsieh, T., Hotaling, J.> ;Plos One. 2024 Jan 1
• Treatment Landscape of Renal Cell Carcinoma.
  Yu-Wei Chen, Luke Wang, Justine Panian, Sohail Dhanji, Ithaar Derweesh, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Current Treatment Options in Oncology. 2023 Dec 1
• Critical elements of pediatric testicular germ cell tumors surgery.
  Amanda F Saltzman, Patrick Hensley, Jonathan Ross, Lynn Woo, Deborah Billmire, Frederick Rescorla, Dhruv Puri, Sunil Patel, Phillip Pierorazio, Aditya Bagrodia, Clint ...> ;Seminars in Pediatric Surgery. 2023 Oct 1
• MicroRNAs for detecting occult genitourinary cancer.
  Nuno Tiago Tavares, João Lobo, Aditya Bagrodia> ;Current Opinion in Urology. 2024 Jan 1
• Sustainability in Urology: Ideas for a Greener Future.
  Kshitij Pandit, Nuphat Yodkhunnatham, Aditya Bagrodia, Manoj Monga> ;European Urology Focus. 2023 Nov 1
• Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy.
  Danielle Urman, Leah Deshler, Nicole Weise, Ahmed Shabaik, Ithaar Derweesh, Aditya Bagrodia, Brent Rose, Daniel Herchenhorn, Rana R McKay> ;Clinical Genitourinary Cancer. 2023 Dec 1
• Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.
  Luca Antonelli, Davide Ardizzone, Isamu Tachibana, Nabil Adra, Clint Cary, Lee Hugar, Wade J Sexton, Aditya Bagrodia, Michal Mego, Siamak Daneshmand, Nicola Nicolai, S...> ;Journal of Clinical Oncology. 2023 Dec 1
• The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement.
  Juan Javier-DesLoges, Marc A Dall'Era, Wayne Brisbane, Karim Chamie, Samuel L Washington 3rd, Thenappan Chandrasekar, Leonard S Marks, Hao Nguyen, Michael Daneshvar, G...> ;Prostate Cancer and Prostatic Diseases. 2023 Aug 8
• Editorial Comment.
  Juan Javier-DesLoges, Aditya Bagrodia, E David Crawford, Christopher J Kane> ;The Journal of Urology. 2023 Oct 1
• 2 citations
  Children's Oncology Group's 2023 blueprint for research: Germ cell tumors.
  Roma Bhuta, Rachana Shah, Jenny N Poynter, Aditya Bagrodia, Bryan J Dicken, Farzana Pashankar, A Lindsay Frazier, Furqan Shaikh, Gell, J. J., Joanna J Gell> ;Pediatric Blood & Cancer. 2023 Sep 1
• 1 citations
  Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor.
  Nikit Venishetty, Jacob Taylor, Yin Xi, Jeffrey M Howard, Yee Seng Ng, Daniel Wong, Solomon L Woldu, Alberto Diaz De Leon, Ivan Pedrosa, Vitaly Margulis, Aditya Bagrodia> ;Clinical Genitourinary Cancer. 2024 Feb 1
• 3 citations
  Novel approaches to redesign surveillance strategies following orchiectomy for localized testicular cancer: a narrative review.
  Richard S Matulewicz, Christian D Fankhauser, Joel Sheinfeld, Aditya Bagrodia> ;Translational Andrology and Urology. 2023 Jun 30
• 5 citations
  Refining the serum miR-371a-3p test for viable germ cell tumor detection.
  John T Lafin, Cinzia G Scarpini, Armon Amini, Bendu Konneh, Jeffrey M Howard, Thomas Gerald, Michelle Nuno, Jin Piao, Anna Savelyeva, Zhaohui Wang, Jeffrey Gagan, Liwe...> ;Scientific Reports. 2023 Jun 29
• Imaging Techniques to Differentiate Benign Testicular Masses from Germ Cell Tumors.
  Ava Saidian, Aditya Bagrodia> ;Current Urology Reports. 2023 Sep 1
• 3 citations
  Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence.
  Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqa...> ;Nature Communications. 2023 May 6
• Join now to see all

Journal Articles

• Clonal Relatedness and Mutational Differences Between Upper Tract and Bladder Urothelial Carcinoma  
  Aditya Bagrodia, Paari Murugan, Clinical Cancer Research
• Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study  
  Passoni NM, Shariat SF, Bagrodia A, Francis F, Rachakonda V, Xylinas E, et al., Bl Cancer, 1/1/2016
• Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?  
  Krabbe LM, Bagrodia A, Westerman ME, Gayed BA, Haddad AQ, Sagalowsky AI, et al., World J Urol, 1/1/2016
• Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned  
  Gayed BA, Youssef R, Darwish O, Kapur P, Bagrodia A, Brugarolas J, et al., BMC Urol., 1/1/2016
• Genomic characterization of response to chemoradiation in urothelial bladder cancer  
  Desai NB, Scott SN, Zabor EC, Cha EK, Hreiki J, Sfakianos JP, et al, Cancer, 1/1/2016
• Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma  
  Bagrodia A, Cha EK, Sfakianos JP, Zabor EC, Bochner BH, Al-Ahmadie HA, et al., J Urol., 1/1/2016
• Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer  
  Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, et al., Nat Genet, 1/1/2016
• Prognostic Genetic Signatures in Upper Tract Urothelial Carcinoma  
  Li Q, Bagrodia A, Cha EK, Coleman JA, Current urology reports, 1/1/2016
• Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma  
  Singla N, Gayed BA, Bagrodia A, Krabbe LM, Palazzi KL, Mirheydar H, et al., Urol Oncol, 1/1/2015
• Genomic Characterization of Upper Tract Urothelial Carcinoma  
  Sfakianos JP, Cha EK, Iyer G, Scott SN, Zabor EC, Shah RH,Bagrodia A, et al., Eur Urol, 1/1/2015
• Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract  
  Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, et al., J Urol, 1/1/2015
• Feasibility of obtaining biomarker profiles from endoscopic biopsy specimens in upper tract urothelial carcinoma: preliminary results  
  Gayed BA, Bagrodia A, Gaitonde M, Krabbe LM, Meissner M, Kapur P, et al, Urol Oncol, 1/1/2015
• Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources  
  Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, et al., J Urol, 1/1/2014
• Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy  
  Shariat SF, Passoni N, Bagrodia A, Rachakonda V, Xylinas E, Robinson B, et al., BJU Int, 1/1/2014
• Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a revie...  
  Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, et al., Urol Oncol, 1/1/2014
• Dysregulation of beta-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma  
  Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Darwish OM, Haddad AQ, et al., J Urol, 1/1/2014
• Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?  
  Krabbe LM, Lotan Y, Bagrodia A, Gayed BA, Darwish OM, Youssef RF, et al., J Urol, 1/1/2014
• Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma  
  Krabbe LM, Bagrodia A, Lotan Y, Gayed BA, Darwish OM, Youssef RF, et al., J Urol, 1/1/2014
• Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma  
  Gayed BA, Youssef RF, Bagrodia A, Darwish OM, Kapur P, Sagalowsky A, et al., BJU Int, 1/1/2014
• Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract  
  Chung PH, Krabbe LM, Darwish OM, Westerman ME, Bagrodia A, Gayed BA, et al., Urol Oncol, 1/1/2014
• Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival  
  Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, et al., Urol Oncol, 1/1/2014
• Impact of renal surgery for cortical neoplasms on lipid metabolism  
  Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, et al., BJU Int, 1/1/2014
• Evaluation of anatomic and morphologic nomogram to predict malignant and high-grade disease in a cohort of patients with small renal masses  
  Bagrodia A, Harrow B, Liu ZW, Olweny EO, Faddegon S, Yin G, et al., Urol Oncol., 1/1/2014
• Surgical management of renal cell carcinoma  
  Krabbe LM, Bagrodia A, Margulis V, Wood CG, Seminars in interventional radiology, 1/1/2014
• Diagnosis and management of upper tract urothelial carcinoma  
  Krabbe LM, Bagrodia A, Westerman ME, Margulis V, Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1/1/2014
• Join now to see all